for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

BPRG recovering, large buys going through...

I know some BPRG holders read and write on this and I seriously hope you all end up OK with current slide. The SEO Packaging concept works, they just need the struggling meat packers to stump up the cash to get it rolling and save everyone's bacon!! Come on SEO, or deep brown stuff will come if appeal happens and fails. Still hanging in here with Bosley.

good luck guys-best result... if bprg takes seo over...what a combo!!

tipton, you missed the 1 (million) infront of the 250k

im in with you bosley! will discuss next time at fratelli, peter

hiya peter. got your leaflet.nice! so you finally took the plunge, eh? good on you.

tomorrow sees more on the court case. a judgement is expected on the compensation claim and also if seo have any grounds for appeal. i would imagine there will be a drop in price .hopefully this will be the end of it. if seo are true to form i would also imagine some good news within a short period of time. good luck .... and dont panic.

Lets hope so, then they can both move forward...

bosley...many apologies off to spec savers in the morning

?@tipton

oh dearie me....# when will this thing be over cos its getting right on me tits this is.

rns 1
BioProgress plc

('BioProgress' or 'the Company')

Further success for BioProgress in patent entitlement case


BioProgress plc (AIM: BPRG; NASDAQ: BPRG) announces that in a hearing yesterday
in the dispute between BioProgress Technology Limited and Stanelco Fibre Optics
Limited ('Stanelco'), the UK Patents Court made further rulings following the
previous judgment handed down on 1 October 2004.


The Court made various declarations about which company had invented the process
of sealing water-soluble polymeric materials by radio frequency ('RF') welding
in order to form capsules. These declarations made reference to BioProgress'
sole entitlement to the main claim and all except three subsidiary claims in the
Master Patent. The Court also clarified that BioProgress' entitlement to the
main patent claims in the Master Patent conferred no right upon Stanelco to use
any of the subsidiary processes without the permission of BioProgress.


In its earlier judgment, the Court had held that Stanelco had misused
Bioprogress' confidential information by making the patent filings which founded
the three families of patents. Yesterday, the Court made an Order for the
commencement of the procedure for assessing the amount to be paid in damages by
Stanelco to BioProgress for breach of confidence.


Stanelco was ordered to disclose details of its foreign patent applications, so
that ownership of all patents and patent applications in the Master Patent
family can be dealt with at a further, final hearing in approximately 4-6 weeks
time.


The Court also made an order for costs in favour of BioProgress. Stanelco must
make an interim payment towards these costs of approximately 180,000 within two
weeks.


At the end of the hearing, Stanelco indicated that it had commenced an
application to request the Court to reconsider certain aspects of the previous
judgment. Stanelco was ordered to file its evidence within seven days.


Graham Hind, Chief Executive of BioProgress said: 'We are very pleased that the
Court has confirmed our entitlement to the main patent claims in the Master
Patent and has awarded us interim costs. The Court has made clear directives to
Stanelco as to the course of action it must now take. We remain as comfortable
as we have always been with our position, and will be making no further comment
until the next hearing is concluded.'


- Ends -


doesnt look good for seo.

rns 2

Stanelco plc

Clarification of Patent Entitlement Case

Stanelco finds it necessary to clarify certain information contained within one
of BioProgress' press releases in connection with the litigation between the two
companies.


Stanelco wishes to clarify that the Court has not ordered that Stanelco has to
pay damages to BioProgress. No final Order will be made until Stanelco's
application to admit further evidence, which may result in a reconsideration of
certain of the Judge's findings, has been determined. All the Court has
determined to date are the principles of a mechanism through which any damages
will be assessed, if a final Order for damages is ultimately made.


It is Stanelco's firm position that no damages, or at worst, minimal damages,
will ultimately be found to be payable to BioProgress.

semantics i think. on bprg thread is a write up from someone who was at the court. doesnt look good for seo .

rns 3

CORRECTION Stanelco says has not yet been ordered to pay BioProgress damages
AFX


(Correcting this item from yesterday to show BioProgress never claimed that Stanelco had been ordered to pay damages, but rather at this point only costs)

LONDON (AFX) - Stanelco PLC said the UK Patents Court has not ordered it to pay damages to BioProgress PLC in a dispute over patent applications.

BioProgress earlier said that the court had made an order for Stanelco to pay costs to it, and must make an interim payment towards these costs of about 180,000 stg within two weeks.

However, Stanelco said later that the court will not make a final order until the company's application to admit further evidence, which may result in a reconsideration of some of the judge's findings, has been determined.

The company added that it believes that no damages, or at worst minimal damages, will ultimately be found to be payable to Bioprogress.

ends

will be good when it is over and done with, i think . both companies need to move on . at best it would be good if seo would explain why they feel the need to fight this so much , ( and so badly by some accounts), when there are other and potentialy more profitable parts to seo.

This is going on for ever...what a waste of time...I also have sbe shares but at least I can deal in seo...no wonder being a lawyer is so profitable...when are both companies going to realise they should be out selling their wares

bosley-your point

will be good when it is over and done with, i think . both companies need to move on . at best it would be good if seo would explain why they feel the need to fight this so much , ( and so badly by some accounts), when there are other and potentialy more profitable parts to seo.

YOU said it!-why?

i agree . i dont really see why . i have been assured that the tray lidding part of the business is safe and separate from the court case . why not just accept the ruling , move on and concentrate on building up this side of seo.

This might explain some of it.

Bones - 03 Nov'04 - 23:14 - 1190 of 1201


Big Al - I know Bio have played it down but this case potentially has a large effect going forward as it concerns the Swallo technology which Wyeth are interested in. Ingel (the Stanelco JV with Cardinal Health) is directly affected. Wyeth is Cardinal's biggest customer and Ingel is/was in competition with BPRG potentially.

i have seen that pat. my point is , that, the tray lidding , packaging side of things has huge potential. would it not make more sense to give up what looks like a lost cause and focus on something that has the potential to dwarf the pill coating side as far as earnings are concerned.

bosley...you'r absolutely right get on with the job or at least give some explaination for messing around like this

Bosley, Looks like Tim Freeborn has conveniently disappeared from the face of the earth after making bad recommendations (see article 106 above). No more Tim's tips in Shares Magazine nowadays.

i noticed, hlyeo, but i was in seo long before tf tipped them. did he jump or was he pushed ? and do you know anything chris bourke , who seems to have taken over the role of technophile at shares. hes tipped deal group this week . seems like a good one , but then again , what the f**k do i know ? i still seo is a winner......

Bosley, I bought some of DGM today at 12p. Hope this will go up.